Clinical Trial Update: Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Avastin plus chemotherapy with a cancer stem cell test–guided approach in recurrent ovarian cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Cordgenics, LLC | Conditions: Recurrent Ovarian Cancer | Phase 3 | Status: WITHDRAWN